Sequoia Financial Advisors’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-1,253
Closed -$6K – 379
2019
Q2
$6K Hold
1,253
– – ﹤0.01% 371
2019
Q1
$7K Hold
1,253
– – ﹤0.01% 366
2018
Q4
$5K Hold
1,253
– – ﹤0.01% 297
2018
Q3
$9K Buy
1,253
+503
+67% +$3.88K ﹤0.01% 322
2018
Q2
$7K Sell
750
-129
-15% -$1.58K ﹤0.01% 310
2018
Q1
$14K Hold
879
– – ﹤0.01% 310
2017
Q4
$15K Hold
879
– – ﹤0.01% 307
2017
Q3
$20K Hold
879
– – ﹤0.01% 287
2017
Q2
$24K Hold
879
– – ﹤0.01% 283
2017
Q1
$20K Hold
879
– – ﹤0.01% 283
2016
Q4
$19K Hold
879
– – ﹤0.01% 273
2016
Q3
$30K Hold
879
– – 0.01% 245
2016
Q2
$28K Sell
879
-14
-2% -$511 0.01% 249
2016
Q1
$39K Hold
893
– – 0.01% 197
2015
Q4
$21K Hold
893
– – 0.01% 175
2015
Q3
$21K Buy
+893
New +$23.6K 0.01% 170

Other funds holding NNVC

Sequoia Financial Advisors's NNVC Position: Q3 2019 in Review

Sequoia Financial Advisors sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 1,253 shares — an estimated $6K sold.

Sequoia Financial Advisors first reported a position in NNVC in Q3 2015 and held it in 16 quarters. The position peaked at $39K in Q1 2016. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

  • Sequoia Financial Advisors reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
  • Sequoia Financial Advisors sold 1,253 NanoViricides shares in Q3 2019, an estimated $6K.
  • Sequoia Financial Advisors first reported a position in NanoViricides in Q3 2015 and held it in 16 quarters.
  • Sequoia Financial Advisors's NanoViricides position peaked at $39K in Q1 2016.
  • 17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Sequoia Financial Advisors's 13F filing for Q3 2019, filed 22 Oct 2019.